Optica Coa Llc in Arecibo, PR - Eyewear Supplier

Optica Coa Llc is a Eyewear Supplier based in Arecibo, Puerto Rico. Optica Coa Llc is licensed to practice in * (Not Available) (license number ) and their current practice location is 404 Ave De Diego, Arecibo, Puerto Rico. It can be reached at their office (for appointments etc.) via phone at (787) 878-2758.

NPI number for Optica Coa Llc is 1457818767 and their current mailing address is Po Box 140819, Arecibo, Puerto Rico. Optica Coa Llc does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1457818767.

Contact Information

	Optica Coa Llc
	404 Ave De Diego, Arecibo, PR 00612
	(787) 878-2758
	(787) 817-3531

Healthcare Provider's Profile

Full Name	Optica Coa Llc
Type	Facility
Speciality	Eyewear Supplier
Location	404 Ave De Diego, Arecibo, Puerto Rico
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1457818767
Provider Enumeration Date: 02/22/2019
Last Update Date: 02/22/2019

Medical Identifiers

Medical identifiers for Optica Coa Llc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457818767	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	(* (Not Available))	Secondary
332H00000X	Eyewear Supplier	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Optica Coa Llc is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Optica Coa Llc Po Box 140819, Arecibo, PR 00614-0819 Ph: (787) 878-2758	Optica Coa Llc 404 Ave De Diego, Arecibo, PR 00612 Ph: (787) 878-2758

News Archive

Adding antiplatelet therapy to oral anticoagulants raises risk for TAVR patients with atrial fibrillation

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement had a lower rate of bleeding complications without an increased risk of clotting-related complications compared to patients who took antiplatelet medication in addition to oral anticoagulants, in a trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.

East Meets West to advance hygiene and sanitation practices in Cambodia, Vietnam

East Meets West has received a US $10.9 million grant from the Bill & Melinda Gates Foundation to improve sanitation and hygiene practices among the rural poor in Vietnam and Cambodia.

Weight loss drug Wegovy approved by FDA

The U.S. Food and Drug Administration (FDA) has approved Wegovy (semaglutide) injection (2.4 mg once weekly) as a chronic weight management treatment in obese or overweight adults with a weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), when used along with calorie restriction and physical activity. Wegovy, is a more potent version of Novo Nordisk's diabetes drug semaglutide.

AGA Medical Holdings receives regulatory product approvals and licenses in China

AGA Medical Holdings, Inc. (AGA Medical) has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder "Cribriform."

Optica Coa Llc - in Arecibo, PR